The Australian Research Council (ARC) announced the successful bids for 2023 ARC Centres of Excellence on Friday. Huge congratulations to EQUS Chief Investigators Professor Warwick Bowen and Professor Halina Rubinsztein-Dunlop, who will lead the new ARC Centre of Excellence in Quantum Biotechnology as Centre Director and Deputy Director, respectively. Congratulations also to EQUS Partner Investigator Professor Fedor Jelezko, who will be a Partner Investigator with the new Centre.
ARC Centre of Excellence in Quantum Biotechnology aims to develop paradigm-shifting quantum technologies to observe biological processes and transform our understanding of life. It seeks to create technologies that go far beyond what is possible today, from portable brain imagers to super-fast single-protein sensors, and to use them to unravel key problems, including how enzymes catalyse reactions and how higher brain function emerges from networks of neurons. By building a diverse, multidisciplinary and industry-engaged ecosystem, the Centre means to develop our future leaders at the interface of quantum science and biology, and drive Australian innovation across manufacturing, energy, agriculture, health and national security.
The bid to renew the ARC Centre of Excellence in Gravitational-Wave Discovery (OzGrav) was also successful—congratulations to EQUS Chief Investigator Associate Professor Kirk McKenzie, who will continue as an OzGrav Chief Investigator in the renewed Centre.